Scientists have made new discoveries about a protein involved in graft versus host disease. The protein, NLRP6, appears to have the opposite effect in graft versus host disease (GvHD) to its role in inflammatory bowel disease.
Dr...
2 months ago
A new breakthrough treatment combination could offer improved treatment for patients with acute myeloid leukaemia (AML) after a successful phase Ib/II trial in Australia.
The study, led by Associate Professor Andrew Wei, from the...
2 months ago